Mr Josh Totty J.Totty@hull.ac.uk
NIHR Clinical Lecturer in Plastic Surgery
Evaluating the current standard of care for patients diagnosed with Malignant Melanoma of the head and neck – access to staging and surgical treatment
People Involved
Project Description
Melanoma is the 5th most common cancer in the UK. Treatment is by removing the cancer with an operation. Early spread can be detected through sampling of nearby lymph nodes - sentinel lymph node biopsy (SLNB). SLNB is readily available for patients with melanoma of the torso and limbs, but not everywhere offers SLNB for head and neck melanoma, for a variety of reasons. However, this may result in some patients not having access to new, systemic treatments that prolong life.
In this study, we aim to examine how practice varies nationally, looking at who is offered SLNB after melanoma of the head or neck, what treatments they go on to have, and whether they recover from their melanoma or not, using anonymous, routinely collected data. By doing this, we hope to identify whether SLNB should be made available to everyone in this group.
| Type of Project | Unfunded: Research |
|---|---|
| Status | Project Complete |
| Funder(s) | BAPRAS |
| Value | £0.00 |
| Project Dates | Dec 1, 2022 - Nov 30, 2024 |
You might also like
DRESSINg: DACC in the REduction of Surgical Site INfection Feb 1, 2017 - Jan 31, 2018
A surgical site infection is an infection occurring in the body where surgery has recently taken place. The rates of infection vary according to the type of surgery but may occur in as many as 1 in every 3 or 4 operations. All of these infections cau...
Read More about DRESSINg: DACC in the REduction of Surgical Site INfection.
Depilation Feasibility PPI: The Impact of Depilation upon Wound Healing and Post-Surgical Complications: A Feasibility Study (The DEPILATION-Feasibility STUDY) - Patient and Public Involvement Jul 1, 2021 - Jun 30, 2022
Wound complications such as infection or dehiscence (where all or part of the wound bursts open) are the most common complication following surgery. The cost of infection alone to the NHS may be upwards of £700 million every year.
Infections are m...
Read More about Depilation Feasibility PPI: The Impact of Depilation upon Wound Healing and Post-Surgical Complications: A Feasibility Study (The DEPILATION-Feasibility STUDY) - Patient and Public Involvement.
First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing Mar 1, 2023 - Jan 31, 2025
Background: Chronic wounds, delayed healing and surgical site infection affect a significant number of patients and come at great cost to healthcare providers. They substantially decrease quality of life and may lead to repeated hospital admission, s...
Read More about First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing.
Validation of a mixed digital reporting outcome measure for surgical site infection diagnosis Dec 1, 2022 - Nov 30, 2023
Repeatable identification of infection and personalised care are key priorities for research in vascular surgery, dictated by patients and surgeons alike. However, surgeons are unable to reach a consensus on the best method for diagnosing wound infec...
Read More about Validation of a mixed digital reporting outcome measure for surgical site infection diagnosis.
The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery Oct 1, 2023 - Sep 30, 2026
Aims
This study aims to investigate the role of a new dressing (DACC) in preventing wound infection follow vascular surgery. This dressing has a special coating that binds to bacteria irreversibly, allowing them to be removed. The DACC dressings wil...
Read More about The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery.